l
pneumophila
common
patient
sever
diseas
treat
intens
care
unit
icu
recent
pneumonia
becom
resist
penicillin
macrolid
small
proport
case
also
resist
fluoroquinolon
recent
antimicrobi
use
within
month
associ
resist
class
antibiot
guidelin
emphas
import
recent
prior
antibiot
therapi
prescrib
differ
class
antimicrobi
therapi
also
evid
resist
penicillin
cephalosporin
may
decreas
stabil
wherea
resist
erythromycin
increas
doern
colleagu
use
data
us
center
demonstr
stabl
rate
penicillin
resist
intermedi
resist
high
resist
macrolid
resist
increas
although
efflux
pump
mediat
consid
lowlevel
resist
nevertheless
mean
macrolid
resist
pneumococci
recent
metaanalysi
despit
rel
high
rate
wide
believ
like
attribut
efflux
pump
mechan
laboratori
phenomenon
signific
failur
rate
newer
macrolid
report
fluoroquinolon
resist
less
activ
blactam
ceftriaxon
resist
rate
although
prior
antibiot
use
macrolid
penicillin
cephalosporin
sulfonamid
increas
likelihood
futur
pneumococc
antibiot
resist
agent
case
fluoroquinolon
wherein
pneumococci
resist
antibiot
remain
suscept
fluoroquinolon
fluoroquinolon
clinic
failur
report
mainli
ciprofloxacin
levofloxacin
ciprofloxacin
consid
antipneumococc
fluoroquinolon
levofloxacin
failur
occur
mainli
lower
dose
rang
cap
guidelin
caution
inappropri
overus
fluoroquinolon
ie
acut
bronchiti
hasten
develop
resist
recent
data
suggest
empir
coverag
level
cap
sever
includ
atyp
organ
pneumonia
c
pneumonia
l
pneumophila
although
report
metaanalysi
review
publish
studi
report
differ
outcom
hospit
patient
treat
atyp
coverag
versu
blactam
studi
use
antibiot
includ
mainli
monotherapi
macrolid
quinolon
treatment
regimen
atyp
organ
rather
treatment
regimen
includ
blactam
addit
atyp
coverag
howev
recent
report
arnold
colleagu
evalu
effect
treat
cap
four
differ
worldwid
region
blactam
alon
versu
therapi
includ
atyp
coverag
report
signific
benefit
time
clinic
stabil
decreas
length
stay
decreas
total
mortal
decreas
caprel
mortal
atyp
treat
one
unanticip
result
previou
guidelin
payforperform
measur
recommend
antibiot
patient
cap
administ
within
hour
emerg
depart
ed
triag
patient
respiratori
symptom
pneumonia
inappropri
receiv
antibiot
fact
one
studi
report
patient
admiss
diagnosi
cap
receiv
antibiot
cap
without
radiograph
abnorm
repres
increas
previou
data
studi
final
diagnosi
cap
decreas
data
publicli
avail
local
media
compar
hospit
regard
success
treat
cap
quickli
pine
colleagu
perform
survey
academ
ed
director
chairperson
reveal
believ
receiv
antibiot
within
time
window
would
improv
patient
care
ed
institut
polici
improv
time
antibiot
therapi
patient
suspect
pneumonia
autom
chest
radiograph
cxr
order
triag
priorit
patient
suspect
pneumonia
administ
antibiot
obtain
cxr
result
despit
effort
increas
volum
us
ed
result
overcrowd
made
achiev
qualiti
standard
much
less
like
anoth
sourc
barrier
administ
appropri
antibiot
rapidli
atyp
present
mani
patient
cap
one
studi
found
alter
mental
statu
absenc
fever
absenc
hypoxia
elderli
age
signific
predictor
antibiot
delay
clear
delay
contribut
mortal
pine
colleagu
found
less
sever
ill
nonclass
present
associ
antibiot
delay
anoth
studi
meterski
colleagu
found
cohort
admit
medicar
patient
cap
present
manner
atyp
enough
caus
delay
antibiot
administr
fee
weber
found
mani
outlier
given
antibiot
hour
diagnosi
ed
cap
mani
abnorm
chest
radiograph
two
articl
often
quot
regard
benefit
earli
antibiot
therapi
meehan
colleagu
houck
colleagu
point
other
studi
numer
limit
exampl
sampl
use
taken
nation
pneumonia
project
center
medicar
medicaid
servic
cm
includ
patient
year
age
older
exclud
mani
patient
immunecompromis
condit
moreov
although
assum
patient
treat
studi
emerg
medicin
physician
ed
hospit
admiss
detail
never
describ
anywher
either
paper
fact
term
emerg
depart
even
use
public
sever
recent
editori
opinion
paper
critic
time
recommend
cm
process
chang
window
window
report
purpos
cap
guidelin
chang
focu
absolut
time
frame
recommend
patient
receiv
initi
antibiot
dose
time
ed
admit
hospit
hospit
also
urg
monitor
inappropri
antimicrobi
treatment
patient
cap
patient
come
ed
base
sever
symptom
ed
physician
face
seri
critic
decis
initi
one
must
decid
patient
pneumonia
patient
treat
nation
guidelin
suggest
local
pneumonia
protocol
establish
hospit
patient
treat
hospit
follow
cap
guidelin
shown
improv
outcom
use
local
protocol
facilit
improv
patient
care
document
reimburs
pham
colleagu
report
data
ed
treatment
acut
myocardi
infarct
ami
pneumonia
nation
hospit
ambulatori
medic
care
survey
involv
ed
recommend
antibiot
administ
patient
pneumonia
puls
oximetri
measur
patient
pneumonia
million
opportun
improv
care
excess
death
per
year
associ
current
treatment
ami
pneumonia
data
suggest
continu
improv
ed
physician
valuabl
team
member
develop
local
pneumonia
protocol
hospit
protocol
reflect
local
environ
resourc
patient
popul
factor
consid
develop
redefin
local
pneumonia
protocol
list
obvious
cost
go
expend
hospit
administr
need
convinc
pneumonia
protocol
valuabl
certainli
advers
public
avoid
good
adher
local
pneumonia
protocol
could
costsav
fewer
health
care
dollar
would
spent
identifi
patient
mild
diseas
could
treat
home
inform
guidelin
site
care
provid
import
criteria
cost
differenti
hundr
dollar
outpati
treatment
compar
thousand
dollar
admiss
adher
protocol
also
result
shorter
hospit
stay
cost
save
patient
transport
ed
emerg
medic
technician
emt
initi
vital
sign
obtain
emt
use
profil
patient
one
point
abnorm
variabl
point
assign
adequ
followup
patient
sent
home
ed
physician
hospit
administr
address
sever
issu
incorpor
potenti
solut
local
pneumonia
protocol
ie
provid
oral
antimicrobi
therapi
set
ed
hold
area
initi
observ
make
followup
telephon
call
arrang
ed
followup
visit
patient
without
primari
care
physician
regardless
whether
factor
implement
local
protocol
treatment
patient
cap
collect
subsequ
qualiti
improv
qi
data
key
determin
success
adher
protocol
seem
logic
local
protocol
put
togeth
physician
abid
recommend
recent
data
australia
show
minim
complianc
nation
recommend
howev
document
pneumonia
sever
index
psi
concord
antibiot
recommend
less
educ
effort
critic
part
protocol
implement
underway
improv
accept
complianc
effort
must
includ
defin
educ
campaign
mechan
audit
provid
feedback
ed
physician
ed
qi
committe
decis
made
emerg
depart
patient
pneumonia
patient
pneumonia
usual
present
ed
recent
onset
respiratori
symptom
may
includ
fever
acut
cough
without
sputum
product
dyspnea
tachypnea
chest
pain
unfortun
patient
classic
symptom
elderli
patient
present
symptom
may
even
point
directli
respiratori
system
ie
decreas
mentat
nonspecif
ach
pain
symptom
may
associ
sever
vital
sign
abnorm
immedi
action
may
requir
includ
treatment
sepsi
respiratori
failur
mani
patient
may
pretreat
antimicrobi
agent
person
physician
prior
ed
visit
selfprescrib
symptom
may
resolv
chanc
resolv
may
progress
infrequ
side
effect
antimicrobi
agent
bring
patient
ed
present
respiratori
symptom
may
caus
nonpneumon
ill
ed
physician
identifi
patient
realist
possibl
pneumonia
differenti
patient
present
ill
similar
symptom
see
fig
inform
obtain
histori
physic
examin
help
make
altern
diagnos
less
like
presenc
underli
diseas
medic
histori
may
use
defin
type
pneumonia
profil
sever
metlay
colleagu
report
absenc
vital
sign
abnorm
abnorm
chest
auscult
substanti
reduc
likelihood
cap
sever
studi
includ
emerg
medicin
evidencedbas
review
make
point
one
histor
find
physic
examin
find
combin
find
accur
rule
rule
diagnosi
pneumonia
nevertheless
still
recommend
author
histori
physic
examin
find
help
contribut
diagnosi
pneumonia
thu
concept
perform
complet
histori
physic
examin
find
continu
integr
part
evalu
patient
moreov
pertin
histori
examin
find
help
emerg
physician
determin
certain
organ
like
caus
agent
whether
antimicrobi
resist
like
indic
cxr
suspect
cap
wide
debat
earli
report
heckerl
colleagu
determin
certain
find
fever
tachycardia
decreas
breath
sound
absenc
asthma
predictor
find
cap
cxr
subsequ
studi
suggest
one
symptom
sign
examin
find
statist
power
enough
rule
rule
diagnosi
pneumonia
cxr
absenc
vital
sign
abnorm
coupl
normal
examin
may
nearli
exclud
diagnosi
miss
rate
report
recent
obrien
colleagu
despit
lack
predictor
rule
diagnosi
sever
vital
sign
abnorm
hypoxia
fever
tachycardia
tachypnea
make
diagnosi
pneumonia
like
consensu
recommend
state
cxr
obtain
patient
older
age
year
patient
abnorm
vital
sign
physic
examin
find
presenc
signific
comorbid
cxr
demonstr
acut
infiltr
part
definit
cap
guidelin
unfortun
cxr
rare
suggest
specif
etiolog
multilobar
infiltr
caviti
infiltr
associ
poor
outcom
presenc
pleural
effus
may
suggest
empyema
presenc
hyperinfl
airway
flatten
diaphragm
may
suggest
copd
need
arteri
blood
gase
cautiou
assess
patient
fever
cxr
interpret
congest
heart
failur
chf
coexist
pneumonia
consid
anoth
limit
cxr
despit
fact
consid
gold
standard
mani
also
sever
limit
sensit
specif
one
studi
one
third
admit
patient
found
normal
cxr
admiss
patient
similar
rate
posit
blood
sputum
cultur
although
cxr
still
consid
standard
care
diagnos
cap
highresolut
ct
scan
may
sensit
frequent
cite
studi
chest
radiographi
miss
case
possibl
pneumonia
case
subsequ
diagnos
highresolut
ct
diagnosi
ct
made
even
commonli
given
increas
number
ct
scan
done
rule
common
caus
chest
pain
ct
pulmonari
embolu
studi
rule
pulmonari
embolu
ct
aneurysm
studi
rule
aortic
dissect
precis
role
ct
scan
rule
rule
cap
remain
determin
howev
studi
connect
ct
diagnosi
microbiolog
diagnos
still
lack
pneumonia
communityacquir
pneumonia
health
careassoci
pneumonia
patient
pneumonia
seen
ed
cap
approach
patient
recommend
cap
guidelin
see
fig
previous
mani
ed
studi
pneumonia
lump
pneumonia
case
togeth
ed
physician
must
alert
occasion
patient
pneumonia
hcap
reason
cite
exclud
cap
guidelin
children
age
year
younger
cover
recent
cap
guidelin
patient
expos
environ
alter
select
pressur
antimicrobi
agent
recent
hospit
within
month
resid
chronic
care
facil
nonambulatori
resid
nurs
home
assist
live
facil
consid
hcap
patient
expand
spectrum
etiolog
agent
would
better
address
use
hcap
guidelin
broader
spectrum
therapi
appropri
consult
small
group
patient
suggest
ambulatori
resid
assist
live
facil
would
expect
etiolog
similar
patient
cap
patient
whose
immun
system
compromis
may
pneumonia
caus
typic
commun
organ
wide
varieti
unusu
organ
may
caus
pneumonia
howev
cap
guidelin
exclud
transplant
recipi
lymphat
malign
neutropen
patient
patient
receiv
chemotherapi
highdos
steroid
least
month
hivinfect
patient
count
less
cellsmm
appropri
consult
assist
prescrib
initi
therapi
patient
gener
requir
broader
spectrum
coverag
minim
data
proport
patient
present
ed
pneumonia
cap
versu
hcap
author
experi
patient
present
ed
pneumonia
cap
recent
studi
barn
hospit
st
loui
patient
admit
cultureposit
pneumonia
report
twice
mani
hcap
admiss
cap
admiss
aureu
mrsa
methicillinsensit
staphylococcu
aureu
mssa
pneumonia
p
aeruginosa
h
influenza
common
pathogen
identifi
overal
patient
hcap
frequent
receiv
inadequ
empir
therapi
higher
mortal
rate
patient
cap
inappropri
therapi
mortal
rate
seri
patient
differ
popul
usual
seen
ed
includ
direct
admiss
care
immunecompromis
patient
larg
medic
center
studi
also
address
cultureposit
patient
data
present
emphas
import
obtain
thorough
histor
inform
distinguish
accur
patient
cap
hcap
howev
mani
patient
admit
cap
older
associ
chronic
diseas
stress
hypoxemia
sepsi
may
worsen
mani
condit
musher
colleagu
report
patient
pneumococc
pneumonia
concomit
sever
acut
cardiac
condit
chf
new
worsen
arrhythmia
ami
mortal
significantli
higher
patient
associ
acut
cardiac
event
lichtman
colleagu
review
case
ami
found
patient
also
acut
sever
noncardiac
condit
initi
hour
pneumonia
common
coexist
ill
adjust
mortal
rate
fivefold
greater
patient
ami
addit
acut
sever
ill
ed
physician
must
vigil
patient
one
acut
diseas
sever
pneumonia
patient
treat
previou
recommend
decid
site
type
care
base
part
psi
psi
made
variabl
somewhat
cumbersom
use
mani
ed
guidelin
favor
see
box
design
british
thorac
societi
variabl
requir
newli
develop
confus
c
uremia
u
increas
respiratori
rate
r
decreas
blood
pressur
b
age
older
year
niederman
suggest
two
instrument
complementari
limit
although
psi
use
determin
patient
low
mortal
risk
occasion
underestim
cap
sever
especi
younger
patient
comorbid
ill
one
studi
compar
instrument
patient
ed
success
predict
patient
low
risk
mortal
better
gradat
sever
diseas
howev
patient
score
progress
greater
mortal
rate
compar
psi
two
categori
sever
ill
iv
v
interestingli
tool
design
predict
mortal
determin
optim
site
care
renaud
colleagu
found
routin
use
psi
increas
percentag
patient
psi
class
ii
treat
outpati
compar
ed
psi
routin
use
increas
outpati
treatment
associ
compromis
patient
safeti
accompani
editori
marri
emphas
need
prospect
trial
patient
discharg
ed
manag
ambulatori
basi
common
recommend
patient
psi
class
ii
score
gener
consid
low
risk
may
consid
outpati
treatment
see
fig
patient
mild
pneumonia
low
mortal
rate
prefer
treat
home
physician
judgment
overrid
site
care
suggest
low
psi
score
certain
circumst
see
fig
patient
appear
sicker
mild
pneumonia
perhap
underli
diseas
chf
coronari
arteri
diseas
diabet
copd
exacerb
perhap
patient
hypoxem
requir
oxygen
supplement
even
though
respiratori
rate
less
breath
per
minut
perhap
pneumonia
sever
yet
associ
system
dysfunct
ie
multilobar
infiltr
cavitari
diseas
patient
must
abl
fill
potenti
expens
prescript
time
fashion
toler
reliabl
take
antimicrobi
therapi
adequ
supervis
avail
patient
subsequ
hour
adequ
medic
followup
arrang
ed
physician
hospit
administr
address
sever
issu
incorpor
potenti
solut
local
pneumonia
protocol
ie
provid
oral
antimicrobi
therapi
initi
dose
prescript
fill
set
ed
hold
area
initi
observ
make
followup
telephon
call
arrang
ed
followup
visit
patient
without
primari
care
physician
cost
treat
patient
pneumonia
home
hundr
dollar
versu
thousand
dollar
treat
patient
hospit
innov
partnership
nurs
home
physician
may
prevent
hospit
patient
better
treat
nurs
home
patient
indic
prefer
hospit
patient
mild
pneumonia
confound
problem
list
previous
may
requir
admiss
gener
medic
ward
patient
admit
hospit
moder
diseas
admit
gener
medic
ward
mortal
rate
group
increas
mortal
rate
among
patient
initi
admit
medic
ward
later
transfer
icu
reason
intens
care
usual
progress
respiratori
failur
difficult
predict
heterogen
popul
develop
clinic
deterior
admiss
guidelin
suggest
cautiou
assess
patient
hypothermia
multilobar
infiltr
leukopenia
thrombocytopenia
recent
data
suggest
patient
copd
cap
higher
mortal
rate
frequent
requir
mechan
ventil
approxim
admit
patient
go
directli
icu
patient
requir
ventilatori
support
patient
septic
shock
respiratori
insuffici
admit
directli
icu
patient
sever
diseas
usual
admit
icu
mortal
high
popul
recent
data
spain
patient
cap
admit
icu
report
delay
ed
longer
hour
obtain
puls
oximetri
result
delay
initi
antibiot
therapi
ed
delay
obtain
puls
oximetri
longer
hour
associ
independ
twofold
increas
mortal
studi
obtain
emerg
depart
regard
laboratori
data
puls
oximetri
part
initi
vital
sign
evalu
patient
possibl
diagnosi
pneumonia
patient
mild
diseas
treat
home
minim
addit
laboratori
data
need
sicker
patient
admit
laboratori
studi
includ
blood
urea
nitrogen
bun
complet
blood
cell
count
cbc
differenti
platelet
count
basic
admiss
test
patient
copd
puls
oximetri
suboptim
arteri
blood
gase
necessari
defin
carbon
dioxid
content
urin
antigen
assay
obtain
legionella
pneumococci
sicker
patient
assay
perform
minut
result
avail
ed
physician
time
frame
cbc
result
gener
sever
pneumonia
aggress
diagnost
studi
regard
blood
cultur
debat
costeffect
blood
sputum
cultur
patient
cap
certainli
low
mortal
rate
patient
treat
home
justifi
search
etiolog
agent
critic
routin
obtain
blood
cultur
studi
show
rare
chang
therapi
recent
emerg
medicin
studi
report
blood
cultur
alter
therapi
patient
chang
narrow
therapi
patient
antibiot
broaden
accompani
editori
moran
abrahamian
ration
blood
cultur
still
make
sens
patient
icu
like
bacterem
risk
empir
therapi
inappropri
editori
wall
resnick
issu
critic
jcaho
cm
adopt
origin
polici
requir
blood
cultur
admit
patient
cap
weight
evid
clearli
support
guidelin
recommend
obtain
blood
respiratori
cultur
patient
admit
icu
also
suggest
obtain
blood
cultur
subset
patient
admit
ward
comorbid
condit
associ
potenti
higher
bacterem
rate
blood
cultur
obtain
empir
antimicrobi
therapi
patient
pretreat
antibiot
blood
cultur
still
obtain
appropri
patient
resist
organ
may
present
patient
bacteremia
antimicrobi
suscept
guid
continu
therapi
appropri
switch
oral
agent
valu
microbiolog
examin
sputum
alway
debat
valu
examin
saliva
patient
produc
purul
sputum
howev
import
data
obtain
mrsa
becom
common
pathogen
skin
infect
among
commun
resid
unfortun
like
mrsa
colon
commun
resid
go
becom
common
caus
cap
mrsa
pneumonia
alreadi
seen
children
influenza
gram
stain
appropri
sputum
specimen
diagnost
pneumonia
caus
aureu
sputum
gram
stain
cultur
help
patient
copd
also
cap
patient
frequent
expos
multipl
cours
antibiot
might
resist
pathogen
recent
data
suggest
patient
copd
cap
sicker
higher
mortal
rate
patient
copd
prior
exposur
antibiot
antibioticpressur
environ
assist
decid
whether
empir
therapi
need
cover
antibiot
resist
pneumonia
patient
take
antibiot
past
month
kind
antibiot
recent
hospit
prolong
exposur
medic
outpati
clinic
exposur
day
care
preschool
direct
indirectli
mani
patient
claim
allergi
variou
antimicrobi
agent
import
defin
patient
definit
allerg
symptom
eg
anaphylaxi
hive
rash
upset
stomach
diarrhea
patient
state
allerg
penicillin
import
ask
treat
cephalosporin
antibiot
without
allerg
symptom
recognit
epidemiolog
clue
may
assist
ed
physician
order
empir
therapi
appropri
isol
procedur
consult
epidemiolog
inform
may
specif
individu
patient
exposur
health
care
system
recent
hospit
resid
chronic
extend
care
facil
patient
may
known
exposur
sick
individu
tuberculosi
chicken
pox
measl
histori
alcohol
abus
drug
abus
neurolog
disord
may
suggest
increas
likelihood
aspir
pneumonia
travel
histori
document
patient
varianc
local
pneumonia
protocol
patient
may
visit
commun
higher
rate
resist
pneumococci
patient
may
foreign
countri
outbreak
viral
hemorrhag
fever
sever
acut
respiratori
syndrom
sar
avian
influenza
recent
cruis
whirlpool
spa
exposur
travel
away
home
past
week
may
associ
legionnair
diseas
anim
bird
exposur
occur
consid
follow
associ
rabbit
hunt
tularemia
psittacin
bird
psittacosi
cattl
pregnant
cat
q
fever
cave
explor
bat
exposur
histoplasmosi
similarli
type
employ
document
ie
day
care
preschool
chronic
care
extend
care
facil
laboratori
worker
pet
store
employe
importantli
patient
resid
chronic
care
assist
live
facil
ambulatori
physic
examin
may
suggest
particular
diagnos
import
coexist
ill
includ
mental
statu
chang
recent
chang
abil
recogn
person
place
time
patient
neurolog
disord
drug
alcohol
abus
may
increas
incid
aspir
pneumonia
intraven
drug
abus
may
associ
undiagnos
hiv
infect
presenc
nuchal
rigid
mening
may
also
present
red
swollen
tender
joint
septic
arthriti
may
present
rash
varicella
rubeola
hemorrhag
fever
stigmata
intraven
drug
alcohol
abus
may
present
lung
examin
auscultatori
find
may
indic
consolid
dull
percuss
diminish
breath
sound
may
also
suggest
pleural
effus
may
suggest
obtain
later
decubitu
film
sign
copd
use
categor
patient
suggest
need
measur
arteri
blood
gase
cardiac
examin
may
reveal
pericard
sign
chf
abdomin
examin
may
assist
diagnosi
find
consist
cirrhosi
ascit
small
liver
jaundic
extrem
examin
may
reveal
swell
calf
tender
needl
tract
diminish
puls
fig
summar
outpati
empir
treatment
recommend
design
treat
atyp
pathogen
pneumonia
h
influenza
uncompl
cap
newer
macrolid
less
optim
doxycyclin
usual
recommend
problem
local
macrolid
resist
pneumonia
recent
use
antibiot
respiratori
fluoroquinolon
combin
oral
therapi
recommend
although
well
studi
seem
logic
patient
mild
cap
treat
home
receiv
first
dose
oral
antibiot
ed
unless
prescript
fill
immedi
regard
macrolid
azithromycin
clarithromycin
better
toler
erythromycin
azithromycin
better
activ
h
influenza
doxycyclin
macrolid
altern
less
expens
although
data
comparison
trial
regard
respiratori
fluoroquinolon
moxifloxacin
gemifloxacin
levofloxacin
good
activ
atyp
pathogen
pneumonia
h
influenza
regard
oral
blactam
use
macrolid
outpati
therapi
highdos
amoxicillin
g
administ
three
time
daili
amoxicillinsulbactam
g
administ
twice
daili
prefer
guidelin
activ
pneumonia
less
prefer
altern
includ
cefpodoxim
cefuroxim
parenter
ceftriaxon
patient
admit
gener
medic
ward
moder
pneumonia
parenter
antimicrobi
therapi
gener
recommend
see
fig
empir
therapi
design
cover
pneumonia
h
influenza
atyp
pathogen
includ
legionella
spp
two
major
choic
would
combin
therapi
blactam
macrolid
monotherapi
fluoroquinolon
regimen
suboptim
pneumonia
caus
mrsa
gramneg
enter
p
aeruginosa
care
must
taken
search
clue
unusu
circumst
would
make
organ
like
possibl
etiolog
agent
patient
bronchiectasi
copd
frequent
antibiot
cours
obtain
consult
addit
p
aeruginosa
coverag
blactam
parenter
recommend
inpati
includ
ceftriaxon
cefotaxim
ampicillinsulbactam
activ
pneumonia
patient
admit
icu
sever
pneumonia
receiv
broadest
empir
therapi
see
fig
immin
danger
respiratori
failur
death
patient
receiv
combin
therapi
blactam
plu
intraven
azithromycin
intraven
fluoroquinolon
patient
admit
gener
medic
ward
patient
bronchiectasi
copd
associ
frequent
antibiot
therapi
addit
p
aeruginosa
therapi
ad
histor
inform
associ
travel
unusu
live
environ
unusu
exposur
work
leisur
activ
prompt
addit
question
perhap
consult
local
pneumonia
protocol
need
updat
organ
mrsa
becom
commun
problem
penicillin
allergi
may
claim
patient
pneumonia
care
defin
patient
mean
penicillin
allergi
patient
taken
cephalosporin
without
difficulti
type
hypersensit
cephalosporin
may
use
inpati
outpati
macrolid
option
use
respiratori
fluoroquinolon
similarli
patient
admit
medic
ward
macrolid
option
use
fluoroquinolon
rather
combin
therapi
patient
admit
icu
guidelin
recommend
use
respiratori
fluoroquinolon
aztreonam
local
pneumonia
guidelin
need
address
issu
mani
pharmaci
may
stock
aztreonam
appropri
consult
may
help
patient
outbreak
influenza
occur
commun
patient
suspect
influenza
place
respiratori
isol
ed
result
rapid
antigen
test
influenza
posit
antivir
therapi
prescrib
common
caus
bacteri
pneumonia
patient
influenza
pneumonia
organ
consid
includ
aureu
mssa
mrsa
h
influenza
neisseria
meningitidi
concomit
mening
gram
stain
cultur
purul
sputum
may
assist
diagnosi
staphylococc
pneumonia
blood
cultur
obtain
patient
new
area
diagnosi
treatment
emerg
depart
unfortun
antimicrobi
therapi
ed
empir
rapid
diagnost
assay
identifi
etiolog
agent
rapid
assay
detect
pneumonia
antigen
urin
l
pneumophila
serogroup
antigen
urin
throat
swab
influenza
b
antigen
avail
pneumococc
urinari
antigen
detect
highli
specif
adult
popul
pneumococc
pneumonia
rare
recent
within
day
administr
pneumococc
vaccin
may
associ
falseposit
result
pneumococc
urinari
antigen
assay
neg
pneumococc
urinari
antigen
result
exclud
bacterem
pneumococc
pneumonia
posit
legionella
urinari
antigen
assay
result
highli
specif
pneumonia
caus
l
pneumophila
serogroup
neg
urinari
antigen
result
legionella
seen
mild
l
pneumophila
serogroup
diseas
pneumonia
caus
serogroup
speci
legionella
unit
state
case
legionnair
diseas
caus
l
pneumophila
serogroup
influenza
antigen
detect
use
earli
influenza
commun
outbreak
rapid
antigen
detect
kit
approv
us
food
drug
administr
fda
sensit
approxim
influenza
antigen
detect
also
use
immunecompromis
patient
pneumonia
antigen
detect
associ
influenza
replic
antivir
therapi
administ
search
secondari
bacteri
pneumonia
initi
polymeras
chain
reaction
pcr
assay
wide
array
respiratori
pathogen
report
literatur
howev
date
clinic
avail
ed
physician
cost
logist
problem
solv
futur
howev
rapid
antigen
detect
mrsa
develop
would
use
addit
current
empir
regimen
cover
mrsa
current
sputum
gram
stain
rapid
diagnost
test
staphylococc
pneumonia
use
serum
marker
predict
poor
outcom
adjunct
therapi
inflammatori
marker
elev
patient
cap
creactiv
protein
procalcitonin
elev
initi
poorer
outcom
marker
may
use
evalu
immunemodul
therapi
agent
activ
protein
c
steroid
research
continu
possibl
role
adjunct
immunemodul
therapi
patient
sever
cap
review
gorman
colleagu
state
current
data
corticosteroid
recommend
adjunct
treatment
sever
cap
pneumonia
common
diseas
seen
ed
structur
approach
patient
pneumonia
evolv
recent
cap
guidelin
at
idsa
cdc
summar
import
outlin
local
cap
protocol
discuss
approach
patient
pneumonia
present
includ
differenti
diagnosi
cap
noncap
diseas
sever
pneumonia
site
care
initi
therapi
unusu
circumst
